Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07259811Not ApplicableActive Not Recruiting

Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration

Role: collaborator

NCT05355454Not ApplicableCompleted

Study of STYLAGE® XXL for Volume Deficiency in the Mid-Face

Role: collaborator

NCT06950021Not ApplicableNot Yet Recruiting

Safety & Performance of CANOpus PINtuition Surgical Marker Navigation

Role: collaborator

NCT05560490Not ApplicableTerminated

FibroFix Cartilage P Knee Implant Study

Role: collaborator

All 4 trials loaded